Xing Meng

La Jolla Institute for Immunology

H指数:9

被引数:321

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and Intranasal Retention of a Broad-Spectrum Anti-SARS-CoV-2 Monoclonal Antibody SA55 Nasal Spray in Healthy Volunteers: A Phase I Clinical Trial

PHARMACEUTICS

IF5.5

2024-12-310

OAAI

Immunogenicity and safety of an inactivated COVID-19 vaccine (CoronaVac®) co-administered with an inactivated enterovirus type 71 vaccine (Inlive®): A phase 4, randomized, controlled trial

新型冠状病毒肺炎灭活疫苗的免疫原性和安全性 (CoronaVac®) 与灭活的肠病毒71型疫苗 (Inlive®): 第四阶段随机对照试验

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2024-09-230

OAAI

Efficacy, immunogenicity and safety of CoronaVac® in children and adolescents aged 6 months to 17 years: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial

NATURE COMMUNICATIONS

IF15.7

2024-08-060

OAAI

Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-05-150

OAAI

The Indian Ocean Weakens the ENSO Spring Predictability Barrier: Role of the Indian Ocean Basin and Dipole Modes

JOURNAL OF CLIMATE

IF4

2023-12-155

Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile

VACCINES

IF3.4

2023-09-264

OAAI

Le Corre, Nicole; Abarca, Katia; Astudillo, Patricio; Potin, Marcela; Lopez, Sofia; Goldsack, Macarena; Valenzuela, Vania; Schilling, Andrea; Gaete, Victoria; Rubio, Lilian; Calvo, Mario; Twele, Loreto; Gonzalez, Marcela; Fuentes, Daniela; Gutierrez, Valentina; Reyes, Felipe; Tapia, Lorena I.; Villena, Rodolfo; Retamal-Diaz, Angello; Cardenas, Antonio; Alarcon-Bustamante, Eduardo; Meng, Xing; Xin, Qianqian; Gonzalez-Aramundiz, Jose V.; Alvarez-Figueroa, Maria Javiera; Gonzalez, Pablo A.; Bueno, Susan M.; Soto, Jorge A.; Perret, Cecilia; Kalergis, Alexis M.

Neutralizing Antibody Responses against Five SARS-CoV-2 Variants and T Lymphocyte Change after Vaccine Breakthrough Infections from the SARS-CoV-2 Omicron BA.1 Variant in Tianjin, China: A Prospective Study

BIOMEDICAL AND ENVIRONMENTAL SCIENCES

IF4.1

2023-08-011

PRE

Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children

MBIO

IF4.7

2022-12-2017

OAAI

Soto, Jorge A.; Melo-Gonzalez, Felipe; Gutierrez-Vera, Cristian; Schultz, Barbara M.; Berrios-Rojas, Roslye, V; Rivera-Perez, Daniela; Pina-Iturbe, Alejandro; Hoppe-Elsholz, Guillermo; Duarte, Luisa F.; Vazquez, Yaneisi; Moreno-Tapia, Daniela; Rios, Mariana; Palacios, Pablo A.; Garcia-Betancourt, Richard; Santibanez, Alvaro; Pacheco, Gaspar A.; Mendez, Constanza; Andrade, Catalina A.; Silva, Pedro H.; Diethelm-Varela, Benjamin; Astudillo, Patricio; Calvo, Mario; Cardenas, Antonio; Gonzalez, Marcela; Goldsack, Macarena; Gutierrez, Valentina; Potin, Marcela; Schilling, Andrea; Tapia, Lorena, I; Twele, Loreto; Villena, Rodolfo; Grifoni, Alba; Sette, Alessandro; Weiskopf, Daniela; Fasce, Rodrigo A.; Fernandez, Jorge; Mora, Judith; Ramirez, Eugenio; Gaete-Argel, Aracelly; Acevedo, Monica L.; Valiente-Echeverria, Fernando; Soto-Rifo, Ricardo; Retamal-Diaz, Angello; Munoz-Jofre, Nathalia; PedCoronaVac; Meng, Xing; Xin, Qianqian; Alarcon-Bustamante, Eduardo; Gonzalez-Aramundiz, Jose, V; Le Corre, Nicole; Javiera Alvarez-Figueroa, Maria; Gonzalez, Pablo A.; Abarca, Katia; Perret, Cecilia; Carreno, Leandro J.; Bueno, Susan M.; Kalergis, Alexis M.

Lot-to-lot consistency, immunogenicity, and safety of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults: A randomized, double-blind, phase IV trial

健康成人灭活SARS-CoV-2疫苗 (CoronaVac) 的批次一致性，免疫原性和安全性: 一项随机，双盲，IV期试验

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2022-11-286

OAAI

Efficacy and safety of Tripterygium wilfordii Hook. f. for oral lichen planus: Evidence from 18 randomized controlled trials

PHYTOTHERAPY RESEARCH

IF6.3

2020-03-168

PREAI

Fire needle therapy for moderate-severe acne: A PRISMA systematic review far and meta-analysis of randomized controlled trials